Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

Rau, Beate; Lang, Hauke; Koenigsrainer, Alfred; Gockel, Ines; Rau, Horst-Guenter; Seeliger, Hendrik; Lerchenmueller, C.; Reim, Daniel; Wahba, Roger; K. Angele, Martin; Heeg, Steffen; Keck, Tobias; Weimann, Arved; A. Topp, Stefan; Piso, Pompiliu; Brandl, Andreas; Schuele, Silke; Jo, Peter; Pratschke, Johann; Wegel, Sandra; Rehders, Alexander; Moosmann, Nicolas; Gaedcke, Jochen; Heinemann, Volker; Trips, Evelyn; Loeffler, Markus; M. Schlag, Peter; Thuss‐Patience, Peter

doi:10.1200/jco.22.02867

Public

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

Published in Journal of Clinical Oncology • Oct 31, 2023

Authors:

Beate Rau

Hauke Lang

Alfred Koenigsrainer

Abstract

PURPOSE In patients with peritoneal metastasis (PM) from gastric cancer (GC), chemotherapy is the treatment of choice. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are still being debated. This randomized, controlled, open-label, multicenter phase III trial (Eudr...

Subject

Medicine

Hyperthermic intraperitoneal chemotherapy

Chemotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!